Pavel V. Nikitin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Pavel V. Nikitin has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Andrey A. Kuzin
Laboratory for Molecular Medical Diagnostics, Moscow Institute of Physics and Technology (National Research University), Dolgoprudny 141701, Russia
1 shared publication - Artem Yu. Belyaev
Burdenko Neurosurgical Center
1 shared publication - Dmitry Y. Usachev
Burdenko Neurosurgical Center, 125047 Moscow, Russia
1 shared publication - Grigoriy L. Kobyakov
N.N. Burdenko National Medical Research Center of Neurosurgery, Ministry of Health of Russia
1 shared publication - Igor A. Popov
Moscow Institute of Physics and Technology
1 shared publication - P.V. Nikitin
University of Oslo, 0315 Oslo, Norway
1 shared publication
Latest Publications
- 10 October 2025
- Published by Elsevier in Neurobiology of Learning and Memory
- Vol. 222, 108105
The mechanisms of memory traces storage and interaction in snails: Role of DNA methylation and protein synthesis
- 10 October 2025
- Published by Elsevier in Neurobiology of Learning and Memory
- Vol. 222, 108105
The mechanisms of memory traces storage and interaction in snails: Role of DNA methylation and protein synthesis
- Open Access
Cell-Population Dynamics in Diffuse Gliomas during Gliomagenesis and Its Impact on Patient Survival
Diffuse gliomas continue to be an important problem in neuro-oncology. To solve it, studies have considered the issues of molecular pathogenesis from the intratumoral heterogeneity point. Here, we carried out a comparative dynamic analysis of the different cell populations’ content in diffuse gliomas of different molecular profiles and grades, considering the cell populations’ functional properties and the relationship with patient survival, using flow cytometry, immunofluorescence, multiparametric fluorescent in situ hybridization, polymerase chain reaction, and cultural methods. It was shown that an increase in the IDH-mutant astrocytomas and oligodendrogliomas malignancy is accompanied by an increase in stem cells’ proportion and mesenchymal cell populations’ appearance arising from oligodendrocyte-progenitor-like cells with cell plasticity and cells’ hypoxia response programs’ activation. In glioblastomas, malignancy increase is accompanied by an increase in both stem and definitive cells with mesenchymal differentiation, while proneuronal glioma stem cells are the most likely the source of mesenchymal glioma stem cells, which, in hypoxic conditions, further give rise to mesenchymal-like cells. Clinical confirmation was a mesenchymal-like cell and mesenchymal glioma stem cell number, and the hypoxic and plastic molecular programs’ activation degree had a significant effect on relapse-free and overall survival. In general, we built a multi-vector model of diffuse gliomas’ pathogenetic tracing up to the practical plane.
Open AccessCell-Population Dynamics in Diffuse Gliomas during Gliomagenesis and Its Impact on Patient Survival
Diffuse gliomas continue to be an important problem in neuro-oncology. To solve it, studies have considered the issues of molecular pathogenesis from the intratumoral heterogeneity point. Here, we carried out a comparative dynamic analysis of the different cell populations’ content in diffuse gliomas of different molecular profiles and grades, considering the cell populations’ functional properties and the relationship with patient survival, using flow cytometry, immunofluorescence, multiparametric fluorescent in situ hybridization, polymerase chain reaction, and cultural methods. It was shown that an increase in the IDH-mutant astrocytomas and oligodendrogliomas malignancy is accompanied by an increase in stem cells’ proportion and mesenchymal cell populations’ appearance arising from oligodendrocyte-progenitor-like cells with cell plasticity and cells’ hypoxia response programs’ activation. In glioblastomas, malignancy increase is accompanied by an increase in both stem and definitive cells with mesenchymal differentiation, while proneuronal glioma stem cells are the most likely the source of mesenchymal glioma stem cells, which, in hypoxic conditions, further give rise to mesenchymal-like cells. Clinical confirmation was a mesenchymal-like cell and mesenchymal glioma stem cell number, and the hypoxic and plastic molecular programs’ activation degree had a significant effect on relapse-free and overall survival. In general, we built a multi-vector model of diffuse gliomas’ pathogenetic tracing up to the practical plane.